Addressing Drug, Biotechnology, and Device Companies' Payments t...

Courtesy Health Care Renewal  Mon, 12/21/2009 - 14:13

We have frequently discussed how financial relationships among physicians, other health care professionals, and health care academics, on one hand, and drug, biotechnology, medical device and other health care corporations may have adverse effects on patient care and medical teaching and research.  A first step towards addressing these relationships would be their full disclosure.  Here in the US, Senators Grassley (R-Iowa) and Kohl (D-Wisconsin) have been pushing for a Physician Payments Sunshine Act which would require all such companies...

Tags:

 

More related items

New York - Presbyterian Hospital Trustee Advocated...
The dominant theme of Health Care Renewal has been how problems with the leadership of health care organizations have lead to our current state of health care dysfunction. We have discussed...

A Logical Fallacy Affecting Selection of Panelists on...
An old argument used to defend against criticisms of conflicts of interest was just employed in a disturbing context. Expert Removed from FDA Advisory Committee for Having an OpinionAs first...

Will the Citigroup Ruling Challenge Health Care...
A federal judge's refusal to approve yet another cozy settlement that was supposed to resolve allegations of wrong-doing by a giant corporation has left the financial world atwitter. It may...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com